The following procedure codes are effective January 1, 2010, unless otherwise annotated:

A4264#
Permanent implantable contraceptive intratubal occlusion device(s) and delivery system
A4336
Incontinence supply, urethral insert, any type, each
A4360
Disposable external urethral clamp or compression device, with pad and/or pouch, each
A4456
Adhesive remover, wipes, any type, each
A4466#
Garment, belt, sleeve or other covering, elastic or similar stretchable material, any type, each
A9581
Injection, gadoxetate disodium, 1 ml
A9582
Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries
A9583
Injection, gadofosveset trisodium, 1 ml
A9604
Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries
C9254
Injection, lacosamide, 1 mg
C9255
Injection, paliperidone palmitate, 1 mg
C9256
Injection, dexamethasone intravitreal implant, 0.1 mg
C9257
Injection, bevacizumab, 0.25 mg
E0433
Portable liquid oxygen system, rental; home liquefier used to fill portable liquid oxygen containers, includes portable containers, regulator, flowmeter, humidifier, cannula or mask and tubing, with or without supply reservoir and contents gauge
E1036
Multi-positional patient transfer system, extra-wide, with integrated seat, operated by caregiver, patient weight capacity greater than 300 lbs
G0420
Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour
G0421
Face-to-face educational services related to the care of chronic kidney disease; group, per session, per one hour
G0422
Intensive cardiac rehabilitation; with or without continuous ECG monitoring with exercise, per session
G0423
Intensive cardiac rehabilitation; with or without continuous ECG monitoring; without exercise, per session
G0424
Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day
G0425
Initial inpatient telehealth consultation, typically 30 minutes communicating with the patient via telehealth
G0426
Initial inpatient telehealth consultation, typically 50 minutes communicating with the patient via telehealth
G0427
Initial inpatient telehealth consultation, typically 70 minutes or more communicating with the patient via telehealth
G0430
Drug screen, qualitative; multiple drug classes other than chromatographic method, each procedure
G0431
Drug screen, qualitative; single drug class method (e.g., immunoassay, enzyme assay), each drug class
G8545#
I intend to report the hepatitis C measures group
G8546#
I intend to report the Community-Acquired Pneumonia (CAP) measures group
G8547#
I intend to report the Ischemic Vascular Disease (IVD) measures group
G8548#
I intend to report the Heart Failure (HF) measures group
G8549#
All quality actions for the applicable measures in the hepatitis C measures group have been performed for this patient
G8550#
All quality actions for the applicable measures in the Community-Acquired Pneumonia (CAP) measures group have been performed for this patient
G8551#
All quality actions for the applicable measures in the Heart Failure (HF) measures group have been performed for this patient
G8552#
All quality actions for the applicable measures in the Ischemic Vascular Disease (IVD) measures group have been performed for this patient
G8553#
At least one prescription created during the encounter was generated and transmitted electronically using a qualified ERX system
G8556#
Referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation
G8557#
Patient is not eligible for the referral for otologic evaluation measure
G8558#
Not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not specified
G8559#
Patient referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation
G8560#
Patient has a history of active drainage from the ear within the previous 90 days
G8561#
Patient is not eligible for the referral for otologic evaluation for patients with a history of active drainage measure
G8562#
Patient does not have a history of active drainage from the ear within the previous 90 days
G8563#
Patient not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not specified
G8564#
Patient was referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not specified)
G8565#
Verification and documentation of sudden or rapidly progressive hearing loss
G8566#
Patient is not eligible for the “referral for otologic evaluation for sudden or rapidly progressive hearing loss” measure
G8567#
Patient does not have verification and documentation of sudden or rapidly progressive hearing loss
G8568#
Patient was not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not specified)
# Not payable codes